Brian H Dovey
CIK 1207786 · last filed 2019-11-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
OREX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
PRINCETON, NJ 08542
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Bionano Genomics, Inc. (BNGOU) Delisted | 10%+ Owner | 591,184 | — | — | $551.2K | 1 | 2018-08-27 |
| Orexigen Therapeutics, Inc. (OREX) Delisted | Director | 298,755 | — | — | $24.29M | 23 | 2017-07-18 |
| Vyome Holdings, Inc (OBLN) Delisted | 10%+ Owner | 16,523 | $9.15 | $151.2K | $0 | 1 | 2016-10-14 |
| GKOS | 10%+ Owner | 6,501 | $178.27 | $1.16M | $0 | 2 | 2015-07-01 |
| OTONOMY, INC. (OTIC) Delisted | Director | 1,628,262 | $0.08 | $125.4K | $0 | 2 | 2015-05-29 |
| Evofem Biosciences, Inc. (NEOT) Delisted | 10%+ Owner | 515,274 | — | — | $6.86M | 1 | 2014-11-26 |
| Achaogen, Inc. (AKAO) Delisted | 10%+ Owner | 33,890 | — | — | $0 | 1 | 2014-03-17 |
| Dicerna Pharmaceuticals Inc (DRNA) Delisted | 10%+ Owner | 13,004 | $38.22 | $497.0K | $0 | 1 | 2014-02-04 |
| TNDM | 10%+ Owner | 318,906 | $18.90 | $6.03M | $0 | 1 | 2013-11-19 |
| VCYT | 10%+ Owner | 22,730 | $48.20 | $1.10M | $0 | 1 | 2013-11-04 |
| Evoke Pharma Inc (OMED) Delisted | 10%+ Owner | 19,006 | — | — | $0 | 1 | 2013-09-30 |
| Tobira Therapeutics, Inc. (RGDO) Delisted | 10%+ Owner | 47,835 | — | — | $3.00M | 1 | 2013-08-28 |
| Ocera Therapeutics, Inc. (TZYM) Delisted | 10%+ Owner | 7,333 | — | — | $8.00M | 1 | 2013-07-16 |
| Esperion Therapeutics, Inc. (ESPR) Delisted | 10%+ Owner | 1,786,012 | $3.18 | $5.68M | $4.00M | 1 | 2013-07-02 |
| ALIMERA SCIENCES INC (ALIM) Delisted | 10%+ Owner | 534,497 | $5.54 | $2.96M | $3.62M | 5 | 2013-06-24 |
| CADENCE PHARMACEUTICALS INC (CADX) Delisted | 10%+ Owner | 5,130,007 | — | — | $15.68M | 10 | 2013-04-10 |
| ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | 10%+ Owner | 5,772,968 | — | — | $0 | 3 | 2013-01-18 |
| Durata Therapeutics, Inc. (DRTX) Delisted | 10%+ Owner | 3,006,132 | — | — | $7.06M | 1 | 2012-07-24 |
| Clovis Oncology, Inc. (CLVS) Delisted | 10%+ Owner | 1,704,080 | $0.08 | $138.4K | $12.11M | 1 | 2011-11-21 |
| ZOGENIX, INC. (ZGNX) Delisted | 10%+ Owner | 21,156 | $26.68 | $564.4K | $16.40M | 2 | 2011-09-20 |
| NEOSE TECHNOLOGIES INC (NTEC) Delisted | Director | 167,442 | $9.63 | $1.61M | $0 | 3 | 2009-02-11 |
| Paratek Pharmaceuticals, Inc. (NOVC) Delisted | 10%+ Owner | 3,115,960 | — | — | -$514.6K | 3 | 2009-01-30 |
| Volcano Corp (VOLC) Delisted | 10%+ Owner | 90,973 | — | — | -$3.27M | 15 | 2008-07-28 |
| SENORX INC (SENO) Delisted | 10%+ Owner | 24,665 | — | — | $0 | 1 | 2007-04-03 |
Recent Filings · Page 3 of 10
98 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-03-17 | Achaogen, Inc. (AKAO) Delisted | Conv (C) | +2,020,939 | $0 | EDGAR |
| 2014-02-04 | Dicerna Pharmaceuticals Inc (DRNA) Delisted | Conv (C) | +1,765,711 | $0 | EDGAR |
| 2013-11-19 | TNDM | Mixed | +3,243,448 | $0 | EDGAR |
| 2013-11-04 | VCYT | Conv (C) | +3,086,024 | $0 | EDGAR |
| 2013-09-30 | Evoke Pharma Inc (OMED) Delisted | Conv (C) | +1,133,333 | $0 | EDGAR |
| 2013-08-28 | Tobira Therapeutics, Inc. (RGDO) Delisted | Mixed | +2,550,109 | $3.00M | EDGAR |
| 2013-07-31 | — | Buy (P) | +1,327,491 | $8.00M | |
| 2013-07-16 | Ocera Therapeutics, Inc. (TZYM) Delisted | Buy (P) | +1,327,491 | $8.00M | EDGAR |
| 2013-07-02 | Esperion Therapeutics, Inc. (ESPR) Delisted | Mixed | +2,102,188 | $4.00M | EDGAR |
| 2013-06-24 | ALIMERA SCIENCES INC (ALIM) Delisted | Sell (S) | −63,096 | -$316.1K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.